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Background: Celiac disease (CD) is a complex autoimmune disorder that can lead to an inflammatory small
intestinal villous atrophy and malabsorption.
Hartnup disease is an autosomal recessive disorder caused by increased urinary excretion of neutral amino acids.
Co-occurrence of Hartnup disease and CD is extremely rare with only a single case reported.
Case presentation: We report a 3-year girl with chronic diarrhea, Hypoalbuminemia and exfoliative erythema. She
was diagnosed with celiac disease, which did not improve on gluten free diet. Hartnup disease was suspected and
was confirmed by neutral aminoaciduria. Niacin was started and followed by dramatic improvement.
Conclusion: Presence of Celiac and Hartnup disease in single individual is very rare. Complete nutritional
assessment of refractory celiac patient can reveal underlying nutritional deficiency.Background
Dermatoses are frequently the presentation of various
metabolic and malabsorptive syndromes with Celiac
Disease (CD) being the most common one. Celiac dis-
ease is an autoimmune, gluten-dependent enteropathy
that leads to small bowel mucosal damage causing mal-
absorption of ingested nutrients. Exfoliative erythema
can be found among celiac patients due to malabsorp-
tion of many microelements. While Celiac disease is a
relatively common disorder in children, Hartnup dis-
ease is not.
Co-occurrence of Hartnup disease and CD is ex-
tremely rare with only a single case reported.Case presentation
A 3-year-old Palestinian girl was referred with primary
complains of persistent chronic diarrhea and hypoalbu-
menemia since one year of age. Additional symptoms in-
cluded significant photosensitivity and severe scaly skin
rash involving face, neck, lower and upper extremities
(Figure 1).* Correspondence: drmutazsultan@gmail.com
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unless otherwise stated.On further investigation, she also complained of pain-
ful recurring oral ulcers and very low energy level.
She was admitted for severe chronic malnutrition. Her
physical exam was significant for abnormally low growth
parameters (weight 10 kg and height 83 cm; both were
two standard deviations (2SD) below normal), general-
ized pitting edema and mild abdominal distension with-
out organomegly.
Initial evaluation included labs and stool studies.
Abnormalities on initial laboratory evaluation included
anemia (Hgb 10.1 g/dl reference range (11.5-16), and co-
agulation abnormalities (Prothrombin Time17.4 (13-14.5),
INR 1.6, (1-1.14). Other pertinent results: alkaline phos-
phatase 171 U/L (100-320), ALT: 26 U/L (5-45), AST: 34
U/L (10-35), total protein: 6.2 g/dl (6-8), albumin 1.9 g/dl
(3.6-5.20). Of note, rheumatoid factor, anti-nuclear anti-
body, Human Immunodeficiency Virus (HIV) status, vita-
min B12, folate, ferritin level and urine organic acids were
all normal.
Her Celiac screening was abnormal with tissue trans-
glutaminase IgA antibodies (tTG) >200 U/ml (<12) and
total IgA 150 mg/dl (14-123) She underwent upper en-
doscopy which revealed significant duodenal blunting ad
scalloping. Biopsies were consistent with diagnosis of
CD (Marsh scale 3b). Patient was started on nasogastrictral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Patient after treatment: a complete resolution of
previous symptoms.
Figure 1 Initial Presentation: significant photosensitivity with
severe scaly desquamating skin rash and hyperpigmentation
involving the face, neck, lower and upper extremities.
Ciecierega et al. BMC Pediatrics  (2014) 14:311 Page 2 of 3tube feeding with high-protein, gluten-free diet and sup-
plemented with Total Parental Nutrition (TPN), intra-
venous (IV) zinc sulphate, microelements (Pediatrace)
and multivitamins (Infuvite Pediatric). Of note, zinc level
returned normal.
Patient had only mild clinical and laboratory improve-
ment after 2 weeks of aggressive treatment. She required
multiple albumin infusion with only transient improve-
ments. A short-course of parental steroids (Methylpred-
nisolon 2 mg/kg, 10 days) for the suspicion of refractory
CD also did not improve her clinical status. Because of
combination of non-improving clinical course and per-
sistent symptoms, she was re-evaluated and suspected to
have a niacin deficiency (The Pellagra) based on the distri-
bution of the rash, photosensitivity, intractable chronic
diarrhea and low mood (the 4D’s: Diarrhea, Dermatitis,
Dementia and Death). The patient was started on oral nia-
cin (50 mg three times daily) followed shortly by a dra-
matic improvement and subsequent complete resolution
of her symptoms within four weeks from the diagnosis
(Figure 2). Reviewing the dietary history showed that she
was consuming decent amount of protein from fish, meat
and diary products ruling out primary cause of inadequateintake of niacin. Hartnup disease was considered as a sec-
ondary cause of niacin deficiency.
Diagnosis of Hartnup disease was confirmed by pres-
ence of neutral aminoaciduria; her urine aminoacids
chromatography showed increased levels of excreted
neutral amino acids (glutamine, valine, phenylalanine,
leucine, asparagine, citrulline, isoleucine, threonine, ala-
nine, serine, histidine, tyrosine, tryptophan). Her urine
excretion of proline, hydroxyproline and arginine was
normal which differentiates Hartnup disease from other
causes of gross aminoacidurea.
She remains on gluten free diet with daily niacin sup-
plementation with no relapse of any of her symptoms.
Although celiac disease is considered a fairly common
disease with estimated prevalence of up to 2% in general
population (Europe and United States), hartnup disease
is an extremely rare disorder. The overall incidence of
Hartnup disease by newborn screening program is 1 case
per 25,000 births in New South Wales and 1 case per
54,00 in Quebec [1]. There is no available data on the in-
cidence of the disease in Palestine.
CD can be associated with extra-intestinal manifesta-
tions. Among them, several skin pathologies have been
described [2-4]. Dermatitis herpetiformis is a well-
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vesicular eruption, which may leave pigmentation and
scarring [3]. Absence of pruritus and vesicular lesions, in
addition to non resolving rash after gluten free diet
made dermatitis herpetiformis unlikely in our patient.
Exfoliative erythema of malnutrition is a term for skin
lesions caused by a combination of multiple deficiencies in
vitamins, microelements, essential fatty acids and amino
acids. On admission, the provisional diagnosis was malab-
sorption due to underlying Celiac disease with severe
acute malnutrition causing exfoliative erythema. Paren-
teral nutrition, IV zinc and multivitamin supplementa-
tion failed to improve her dermatological manifestations.
Dramatic response to niacin supplement was diagnostic
for pellagra.
Hartnup disorder is an autosomal recessive abnormal-
ity of renal and gastrointestinal neutral amino acid
transport [5,6]. The failure to resorb amino acids in this
disorder is compensated by a protein-rich diet. However,
in combination with a poor diet and other factors like
malabsorption, more severe symptoms can develop.
Hartnup disorder was first described in two siblings of
the Hartnup family in 1956. Soon after its initial descrip-
tion, it was suggested that Hartnup disease results from
a tissue specific failure to resorb neutral amino acids in
the kidney and intestine.
The causative gene, SLC6A19, is located on a locus on
short arm of chromosome 5 (band 5p15.33), which en-
codes a defective transporter [7]. The transporter is
found in kidney and intestine, where it is involved in the
reabsorption of all neutral amino acids. An abnormality
in tryptophan transport leads to niacin deficiency, which
is responsible for the pellagra-like eruptions.
In our case, the severity of the skin lesions can be ex-
plained by the coexistence of two diseases. Most likely
the combined deficiencies in amino acids and proteins
led to exacerbation of hartnup disease, which is asymp-
tomatic in the majority of the cases.
Co-occurrence of Hartnup disease and CD is ex-
tremely rare with only a single case reported [8].Conclusion
Presence of Celiac and Hartnup disease in single individ-
ual is very rare. It appears that CD with its severe enterop-
athy have uncovered the Hartnup disease and magnified
symptoms of niacin deficiency. Complete nutritional as-
sessment of refractory celiac patient can reveal underlying
nutritional deficiency.Consent
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